End-of-day quote
Shanghai S.E.
23:00:00 16/05/2024 BST
|
5-day change
|
1st Jan Change
|
2.44
CNY
|
+2.95%
|
|
+1.24%
|
-23.99%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,990
|
5,631
|
12,165
|
7,461
|
7,627
|
5,797
|
-
|
-
|
Enterprise Value (EV)
1 |
4,990
|
5,631
|
12,165
|
7,461
|
7,627
|
5,797
|
5,797
|
5,797
|
P/E ratio
|
-9.52
x
|
43.6
x
|
28.2
x
|
107
x
|
-5.59
x
|
81.3
x
|
61
x
|
40.7
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
0.65
x
|
0.44
x
|
0.56
x
|
0.38
x
|
0.35
x
|
0.32
x
|
EV / Revenue
|
-
|
-
|
0.65
x
|
0.44
x
|
0.56
x
|
0.38
x
|
0.35
x
|
0.32
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
2.04
x
|
1.24
x
|
1.64
x
|
1.23
x
|
1.21
x
|
1.17
x
|
Nbr of stocks (in thousands)
|
2,375,982
|
2,375,982
|
2,375,982
|
2,375,982
|
2,375,982
|
2,375,982
|
-
|
-
|
Reference price
2 |
2.100
|
2.370
|
5.120
|
3.140
|
3.210
|
2.440
|
2.440
|
2.440
|
Announcement Date
|
27/04/20
|
15/04/21
|
15/04/22
|
14/04/23
|
19/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
18,737
|
17,036
|
13,621
|
15,155
|
16,571
|
17,933
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
705.8
|
32.7
|
-1,452
|
575
|
615
|
647
|
Operating Margin
|
-
|
-
|
3.77%
|
0.19%
|
-10.66%
|
3.79%
|
3.71%
|
3.61%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
656.5
|
26.52
|
-2,267
|
-240
|
-200
|
-168
|
Net income
1 |
-524.2
|
128.9
|
431.7
|
69.96
|
-1,366
|
61
|
101
|
132
|
Net margin
|
-
|
-
|
2.3%
|
0.41%
|
-10.03%
|
0.4%
|
0.61%
|
0.74%
|
EPS
2 |
-0.2206
|
0.0543
|
0.1817
|
0.0294
|
-0.5747
|
0.0300
|
0.0400
|
0.0600
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
27/04/20
|
15/04/21
|
15/04/22
|
14/04/23
|
19/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
2.36%
|
7.51%
|
1.17%
|
-25.6%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
2.09%
|
0.06%
|
-
|
-1.1%
|
-0.9%
|
-0.7%
|
Assets
1 |
-
|
-
|
20,643
|
125,732
|
-
|
-5,545
|
-11,222
|
-18,857
|
Book Value Per Share
2 |
-
|
-
|
2.510
|
2.530
|
1.960
|
1.980
|
2.020
|
2.080
|
Cash Flow per Share
2 |
-
|
-
|
0.4500
|
0.7200
|
0.6100
|
0.4900
|
0.4300
|
0.4600
|
Capex
1 |
-
|
-
|
468
|
289
|
381
|
320
|
320
|
320
|
Capex / Sales
|
-
|
-
|
2.5%
|
1.7%
|
2.79%
|
2.11%
|
1.93%
|
1.78%
|
Announcement Date
|
27/04/20
|
15/04/21
|
15/04/22
|
14/04/23
|
19/04/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -23.99% | 803M | | +5.41% | 106B | | -4.31% | 63.94B | | +73.33% | 49.34B | | +17.24% | 39.15B | | +6.13% | 32.86B | | +12.77% | 20.29B | | +15.03% | 17.21B | | +19.06% | 15.28B | | +6.28% | 14.58B |
Other Commodity Chemicals
|